Maitake α-D-glucan (YM-2A; Grifola frondosa) has been found to enhance host anti-tumour action, activating CD4+ and CD8+ lymphocytes in the spleen and CD8+ cells in tumour-draining lymph nodes. This evidence concerns the gene CD8A and neoplasm.